ADVERTISEMENT

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

APhA Announces 2023 Remington Medal Recipient APhA Announces 2023 Remington Medal Recipient

APhA Announces 2023 Remington Medal Recipient

0 4197

Washington, DC—The American Pharmacists Association (APhA) announced the selection of the 2023 APhA Awards and Honors Program recipients today. The APhA Awards and Honors Program is the most comprehensive recognition program in the profession of pharmacy.

CEO Search Launch Announcement CEO Search Launch Announcement

CEO Search Launch Announcement

0 3814

The search for APhA’s next CEO has launched with the release of the CEO position specification by the APhA Executive Committee, Search Committee, and executive search firm, Russell Reynolds Associates.

American Pharmacists Month Begins Now American Pharmacists Month Begins Now

American Pharmacists Month Begins Now

WASHINGTON, DC – Today, The American Pharmacists Association officially kicked off American Pharmacists Month (APhM). It all started in...
0 4686
APhA Statement on Monkeypox PREP Act Declaration APhA Statement on Monkeypox PREP Act Declaration

APhA Statement on Monkeypox PREP Act Declaration

(WASHINGTON, DC) Ilisa Bernstein, PharmD, JD, FAPhA, interim executive vice president and CEO of the American Pharmacists Association (APhA)...
0 5781

APhA Changes Executive Leadership

The Board of Trustees of the American Pharmacists Association announced today that Ilisa Bernstein, PharmD, JD, FAPhA, has been named Interim CEO, effective immediately. Bernstein’s appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.

First3456781012
Advertisement
Advertisement
Advertisement
Advertisement

ADVERTISEMENT